HX008, an anti-PD1 antibody, plus irinotecan as second-line treatment for advanced gastric or gastroesophageal junction cancer: a multicenter, single-arm phase II trial.

Yan SongNing LiQun LiXinjun LiangShu ZhangQingxia FanXianli YinZhixiang ZhuangYunpeng LiuJingdong ZhangXiaoge KouHaijun ZhongXiaofei WangYiwei DouJing Huang

Published in: Journal for immunotherapy of cancer (2021)

NCT03704246.

Keyphrases

papillary thyroid
open label
young adults